Mechanisms of cell death in Alzheimer's disease: Role of presenilins

被引:0
|
作者
Popescu, BO [1 ]
Ankarcrona, M [1 ]
机构
[1] Karolinska Inst, Neurotec, KFC, Novum, SE-14186 Huddinge, Sweden
关键词
Alzheimer's disease; presenilin; apoptosis; proteasome;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Presenilins are often mutated in familial forms of Alzheimer's disease (AD). Such mutations sensitize cells in culture to different apoptotic stimuli eg. staurosporine, calcium ionophore, growth factor withdrawal. The altered responses to apoptotic stimuli in cells carrying presenilin mutations include increased intracellular calcium concentrations and enhanced production of reactive oxygen species. Presenilin mutations also result in increased production of amyloid beta (Abeta) indicating that presenilins participate in the cleavage of amyloid beta-protein precursor (AbetaPP). In fact, presenilin is part of the gamma-secretase complex which together with beta-secretase cleaves AbetaPP and produce Abeta, later forming the senile plaques typical for AD pathology. Here we review the current knowledge about the mechanisms of cell death in AD with focus on the role of presenilin and presenilin mutations in apoptosis. It appears that presenilin and its different fragments, generated after proteolytic cleavage, have a regulatory role in apoptosis. In addition, different studies show that the cellular levels of presenilin are controlled by proteasomal degradation both under normal and stress conditions.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [31] Mechanisms of neuronal death in Alzheimer's disease
    Cotman, CW
    Su, JH
    BRAIN PATHOLOGY, 1996, 6 (04) : 493 - 506
  • [32] Presenilins as therapeutic targets for the treatment of Alzheimer's disease
    Golde, TE
    Koo, ED
    Weggen, S
    Sagi, SA
    Monnier, T
    Nyborg, A
    Das, P
    Jansen, K
    Eriksen, J
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 84 - 84
  • [33] The Molecular Mechanisms of Neuroinflammation in Alzheimer's Disease, the Consequence of Neural Cell Death
    Choi, Su-Bin
    Kwon, Sehee
    Kim, Ji-Hye
    Ahn, Na-Hyun
    Lee, Joo-Hee
    Yang, Seung-Hoon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [34] Presenilins, Alzheimer's disease, and capacitative calcium entry
    Putney, JW
    NEURON, 2000, 27 (03) : 411 - 412
  • [35] Chromosome missegregation in Alzheimer's Disease caused by the presenilins
    Boeras, DI
    Padmanabhan, J
    Sutcliffe, M
    Nilsson, L
    Potter, H
    FASEB JOURNAL, 2002, 16 (04): : A526 - A527
  • [36] Presenilins as therapeutic targets for the treatment of Alzheimer's disease
    Golde, TE
    Younkin, SG
    TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) : 264 - 269
  • [37] Amyloid β peptides and presenilins in the pathogenesis of Alzheimer's disease
    Iwatsubo, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1999, 32 (01) : 13 - 15
  • [38] Presenilins and early-onset Alzheimer's disease
    van Duijn, CM
    Cruts, M
    Backhovens, H
    Theuns, J
    Van Gassen, G
    Hofman, A
    Van Broeckhoven, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A214 - A214
  • [39] Presenilins: Discovery and characterization of the genes of Alzheimer's disease
    Rogaev, EI
    MOLECULAR BIOLOGY, 1998, 32 (01) : 58 - 69
  • [40] Presenilins, amyloid-beta and Alzheimer's disease
    Lamb, BT
    NATURE MEDICINE, 1997, 3 (01) : 28 - 29